Novartis ($NVS) was all set to close the door on a Sandoz intermediates plant in Germany last year, thanks to some hefty competition from Asia. But now, the Swiss pharma giant has a buyer willing to take the plant--and salvage the 270 jobs that would have been chopped. More from FiercePharmaManufacturing

@FiercePharma:Dana-Farber and MIT team says financial engineering could help pay for big-ticket meds. More | Follow @FiercePharma

> Sanofi ($SNY) won European approval for its diabetes-focused joint venture with Google's parent company Alphabet ($GOOG). Report

> India's Lupin plans to invest in Japan, with hopes of getting 20 drugs to market there in the coming quarters. Report

> In amicus briefs, two pharma industry groups urged the Third Circuit to affirm a lower court ruling that tossed out a pay-for-delay case against Pfizer's ($PFE) Wyeth unit and generics maker Teva ($TEVA). Report

> Pfizer asked a U.S. district judge to bar some expert testimony in pending lawsuits over alleged birth defects linked to its antidepressant Zoloft; Legal Intelligencer judged the litigation "on the verge of collapse." Report

Medical Device News

@FierceMedDev: Propeller partners with Aptar in hopes of winning race to first integrated 'smart' inhaler. Story | Follow @FierceMedDev

> Boston Scientific's Brazilian operations under investigation, as co-founder to depart. More